Abbott Laboratories v. Geneva Pharmaceuticals, Inc.
528 U.S. 1078, 120 S. Ct. 796, 145 L. Ed. 2d 671, 68 U.S.L.W. 3430, 2000 U.S. LEXIS 169
Supreme Court of the United States·Decided January 10, 2000·No. No. 99-753·Published·Cited by 4 cases
Opinion
C. A. Fed. Cir. Certiorari denied.
Free access — add to your briefcase to read the full text and ask questions with AI
Abbott Laboratories v. Geneva Pharmaceuticals, Inc., 528 U.S. 1078, 120 S. Ct. 796, 145 L. Ed. 2d 671, 68 U.S.L.W. 3430, 2000 U.S. LEXIS 169 (2000).
528 U.S. 1078 (Abbott Laboratories v. Geneva Pharmaceuticals, Inc.) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.
Related
MGE UPS Systems, Inc. v. Fakouri Electrical Engineering, Inc.
422 F. Supp. 2d 724 (N.D. Texas, 2006)
Valley Drug Company v. Geneva Pharmaceuticals, Inc.
344 F.3d 1294 (Eleventh Circuit, 2003)
Scaltech, Inc. v. Retec/tetra, LLC, Defendant-Cross
269 F.3d 1321 (Federal Circuit, 2001)
Honeywell International Inc. v. Hamilton Sundstrand Corp.
166 F. Supp. 2d 1008 (D. Delaware, 2001)